Form4insider filings, from the source

SEC Form 4 · accession 0001209191-15-081095

Atara Biotherapeutics, Inc. · ATRA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
John McGrath
Officer — Chief Financial Officer
Period of report
Nov 16, 2015
Accepted (ET)
Nov 18, 2015 · 6:58 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001604464

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Nov 16, 2015M2,805$0.00A34,659D
Common StockF1Nov 16, 2015M7,697$0.00A42,356D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitsF5,F2,F3,F4—Nov 16, 2015M2,805D——Common Stock2,80514,957I
Restricted Stock UnitsF5,F2,F6,F7—Nov 16, 2015M7,697D——Common Stock7,69766,711I

Explanation of responses